Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions

Table 5 Clinical Outcome of diabetes subjects based on MAGE levels during in-hospital and 30-day follow-up

MAGE (mmol/L)		<2.84	2.84-3.96	>3.96	P
Subject number (n)	73	24	24	25	NA
Composite MACE	18 (24.7)	2 (8.3)	6 (25)	10 (40)	0.038
Non-IRA revascularization	27 (37)	4 (15)	10 (21)	13 (32)	0.032

Data given as n (%).
MAGE, the mean amplitude of glycemic excursions; MACE, major adverse cardiac events; TVR, target vessel revascularization; IRA, infarct related arteries.